Diagnosis and treatment of a rare sinonasal neuroendocrine tumour: adding to the evidence

Sinonasal neuroendocrine tumours (NETs) are rare, aggressive neoplasms with a high recurrence potential. There are no robust protocols for the management of these tumours. An 81-year-old man presented with an incidental sinonasal mass visualised on CT scan of head. Over the next few weeks he developed new onset, progressively worsening headache, right eye ptosis and restricted extraocular movements. Imaging confirmed a rapidly enlarging tumour involving the right nasal cavity and the orbit. Biopsy showed a large cell neuroendocrine carcinoma of the right ethmoidal sinus. The patient was treated with concurrent cisplatin chemotherapy and radiation. Repeat imaging showed decrease in tumour volume. The patient continues to do well and follows up regularly with our oncology service. Current protocols comprising chemotherapy after radiation are based on limited studies. A regimen involving concurrent chemoradiation also appears to aid in tumour volume reduction. Additional studies are required to formulate robust clinical protocols for management of sinonasal NETs.

[1]  Marino E. Leon,et al.  Sinonasal small round blue cell tumors: An approach to diagnosis. , 2016, Seminars in diagnostic pathology.

[2]  A. Haddad,et al.  Primary neuroendocrine tumors of the ear, nose and throat: A report of three cases and a review of the literature. , 2015, Oncology letters.

[3]  Wen-rong Zhu,et al.  The CT and MRI observations of small cell neuroendocrine carcinoma in paranasal sinuses , 2015, World Journal of Surgical Oncology.

[4]  J. Bishop,et al.  Primary Small Cell Neuroendocrine Carcinoma of Paranasal Sinuses , 2014, Case reports in medicine.

[5]  D. Cuthbertson,et al.  Treatment of orbital metastases from a primary midgut neuroendocrine tumor with peptide-receptor radiolabeled therapy using 177 lutetium-DOTATATE. , 2013, Journal of Clinical Oncology.

[6]  U. Das,et al.  Paranasal Sinus Neuroendocrine Carcinoma: A Case Report and Review of the Literature , 2013, Case reports in oncological medicine.

[7]  Nicholas B. Levine,et al.  Multimodality treatment for sinonasal neuroendocrine carcinoma , 2012, Head & neck.

[8]  J. Shang,et al.  [Diagnosis and treatment of 11 cases with sinonasal neuroendocrine carcinoma]. , 2011, Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery.

[9]  A. El‐Naggar,et al.  Sinonasal neuroendocrine carcinoma: impact of differentiation status on response and outcome , 2011, Head & neck oncology.

[10]  Ben Lawrence,et al.  The epidemiology of gastroenteropancreatic neuroendocrine tumors. , 2011, Endocrinology and metabolism clinics of North America.

[11]  Domenico Coppola,et al.  The Pathologic Classification of Neuroendocrine Tumors: A Review of Nomenclature, Grading, and Staging Systems , 2010, Pancreas.

[12]  C. Shu,et al.  Sino-nasal neuro-endocrine carcinoma. , 2010, Acta oto-laryngologica.

[13]  L. Barnes,et al.  Pathology and genetics of head and neck tumours , 2005 .

[14]  Stanley J. Rosenthal,et al.  Neuroendocrine tumors of the sinonasal tract , 2002, Cancer.

[15]  K. Chao,et al.  Esthesioneuroblastoma: The impact of treatment modality , 2001, Head & neck.

[16]  P. Hazarika,et al.  Recurrent metastasi zing neuroendocrine tumor of paranasal sinuses , 2000, Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India.

[17]  U. Baum,et al.  Paranasal sinuses and nasopharynx CT and MRI. , 2000, European journal of radiology.

[18]  N. Bhattacharyya,et al.  Successful treatment of esthesioneuroblastoma and neuroendocrine carcinoma with combined chemotherapy and proton radiation. Results in 9 cases. , 1997, Archives of otolaryngology--head & neck surgery.

[19]  C. C. Wang,et al.  Olfactory neuroblastoma—A clinical analysis of 17 cases , 1976, Cancer.